Marché mondial des carcinoïdes bronchiques – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché des carcinoïdes bronchiques

Le marché mondial des tumeurs carcinoïdes bronchiques devrait connaître une croissance significative au cours de la période de prévision. La tumeur carcinoïde est un type rare de trouble malin qui représente moins de 1 % de tous les troubles malins. Environ 2 à 4 tumeurs carcinoïdes sur 10 se trouvent dans les poumons. La cause des tumeurs carcinoïdes pulmonaires est encore inconnue. L'augmentation des cas de tumeurs carcinoïdes, de carcinomes mucoépidermoïdes et d'antécédents familiaux de troubles pulmonaires stimule le marché des tumeurs carcinoïdes bronchiques. Le COVID-19 a également eu un impact majeur sur la croissance du marché.

Data Bridge Market Research analyse le taux de croissance du marché mondial des carcinoïdes bronchiques au cours de la période de prévision 2022-2029. Le marché mondial des carcinoïdes bronchiques a tendance à avoir un TCAC sain au cours de la période de prévision mentionnée. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe Data Bridge Market Research comprend également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des carcinoïdes bronchiques

Market Definition

Bronchial carcinoid is uncommon, rare disorder that affects 1 to 2% of all lung cancers in adults. It is a slow growing neuroendocrine tumors and low-grade malignant neoplasms rising from bronchial mucosa. Central bronchial carcinoids are common compared to the peripheral and produces symptoms including bronchial obstruction such as cough, localized wheeze, non-resolving recurrent pneumonitis, chest pain, and fever. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.

Global Bronchial Carcinoid Market Dynamics

Drivers

• Increase in Lung Cancer

According to the GLOBOCAN 2020 estimates by the International Agency for Research on Cancer, about 19.3 million new cases of cancer recorded in 2020 and around 11.4% of them were lung cancer. Lung cancer was the primary cause of death with about 18% or 1.8 million global deaths in 2020. Thus this increasing lung cancer result in the origin of bronchial carcinoid and in return this boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global bronchial carcinoid market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increase in Geriatric Population

The elderly population is projected to increase the patient population worldwide, which boots the market in the forecast period. As per the reports of WHO, the global elderly population is anticipated to reach about 2 billion by 2050 from 617 million in 2015. The range of possibility of getting infected with varied types of cancer also rises. This boost the market growth.

• Higher Indulgence of  Advanced Therapies

The rapid growth of the biopharmaceutical industry and the increasing R&D expenses have resulted in the development of several advanced targeted therapeutics to treat lung cancer. The targeted therapy can efficiently treat cancer cells without altering the body's normal cells. This results in nominal side-effects and removes the chances of reoccurrence and deaths. The rising healthcare expenditure combined with the rising awareness associated with the availability of advanced gene therapies that can cure traditionally non-curable diseases has significantly boosted the growth of the targeted therapy across the globe. This creates more opportunities in the market.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are not aware of the appropriate treatment methods for this disease could restrain the growth of the global bronchial carcinoid market over a forecast period.

• High Cost

The huge expenditure of the treatment methods such as radiation therapy, chemotherapy, medications are hamper the market growth.

This global bronchial carcinoid market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bronchial carcinoid market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Bronchial Carcinoid Market Scope

The global bronchial carcinoid market is segmented on the basis of type, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Central Bronchial Carcinoids
• Peripheral Bronchial Carcinoids
• Others

Treatment Type

• Surgery
• Radiation Therapy
• Chemotherapy
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Bronchial Carcinoid Market Regional Analysis/Insights

The global bronchial carcinoid market  is analysed and market size insights and trends are provided by type, treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global bronchial carcinoid market  report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to presence of advanced technology and high R&D & healthcare expenditure.

Asia-Pacific dominates the market due to growing geriatric population suffering from lung disorder, increased usage of cigarettes & alcohol and presence of generic manufacturers.

La section par pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché mondiales du carcinoïde bronchique

Le paysage concurrentiel du marché mondial des carcinoïdes bronchiques fournit des détails par concurrent. Les détails comprennent un aperçu de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial des carcinoïdes bronchiques.

Les principaux acteurs opérant sur le marché mondial du carcinoïde bronchique comprennent :

• Johnson & Johnson Private Limited (États-Unis)
• Cipla Inc. (États-Unis)
• Abbott (États-Unis)
• AbbVie Inc. (États-Unis)
• Sun Pharmaceutical Industries Ltd. (Inde)
• Lupin (Inde)
• Hikma Pharmaceuticals PLC (Royaume-Uni)
• Amneal Pharmaceuticals LLC. (États-Unis)
• Pfizer Inc (États-Unis)
• Mylan NV (États-Unis)
• Société Bristol-Myers Squibb (États-Unis)
• GSK plc. (Royaume-Uni)
• Bayer AG (Allemagne)
• NATCO Pharma Limited (Inde)
• Shilpa Therapeutics Private Ltd. (Inde)

SKU-54193